DCM
AGTC

DAFNA Capital Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

DAFNA Capital Management’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-430,111
Closed -$2.18M – 96
2021
Q1 		$2.18M Sell
430,111
-473,318
-52% -$2.46M 0.52% 46
2020
Q4 		$3.69M Sell
903,429
-191,710
-18% -$942K 1.1% 24
2020
Q3 		$5.32M Sell
1,095,139
-65,739
-6% -$359K 1.73% 16
2020
Q2 		$6.43M Hold
1,160,878
– – 1.86% 15
2020
Q1 		$3.81M Buy
1,160,878
+801,688
+223% +$4.22M 1.59% 19
2019
Q4 		$1.62M Hold
359,190
– – 0.56% 43
2019
Q3 		$1.49M Hold
359,190
– – 0.56% 47
2019
Q2 		$1.36M Hold
359,190
– – 0.51% 52
2019
Q1 		$1.5M Hold
359,190
– – 0.65% 44
2018
Q4 		$894K Sell
359,190
-670
-0.2% -$3.92K 0.44% 52
2018
Q3 		$2.63M Sell
359,860
-61,140
-15% -$268K 1.08% 33
2018
Q2 		$1.56M Hold
421,000
– – 0.73% 39
2018
Q1 		$1.62M Hold
421,000
– – 0.79% 37
2017
Q4 		$1.52M Hold
421,000
– – 0.82% 37
2017
Q3 		$1.66M Hold
421,000
– – 1.03% 31
2017
Q2 		$2.15M Buy
421,000
+10,000
+2% +$56.2K 1.53% 20
2017
Q1 		$2.84M Buy
411,000
+124,702
+44% +$974K 2.4% 10
2016
Q4 		$2.68M Buy
286,298
+46,000
+19% +$414K 2.35% 13
2016
Q3 		$2.35M Buy
240,298
+73,106
+44% +$986K 1.64% 20
2016
Q2 		$2.36M Hold
167,192
– – 1.87% 16
2016
Q1 		$2.34M Buy
167,192
+10,000
+6% +$147K 2.02% 15
2015
Q4 		$3.21M Hold
157,192
– – 2.86% 10
2015
Q3 		$2.07M Hold
157,192
– – 2.05% 14
2015
Q2 		$2.41M Buy
157,192
+47,869
+44% +$918K 2.04% 17
2015
Q1 		$2.19M Buy
+109,323
New +$2.44M 1.68% 16

Other funds holding AGTC

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

DAFNA Capital Management's AGTC Position: Q2 2021 in Review

DAFNA Capital Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2021, closing a stake of 430,111 shares — an estimated $2.18M sold.

DAFNA Capital Management first reported a position in AGTC in Q1 2015 and held it in 25 quarters. The position peaked at $6.43M in Q2 2020. 71 funds tracked by Wall St. Rank hold AGTC as of Q2 2021.

  • DAFNA Capital Management reported no remaining Applied Genetic Technologies Corporation position as of Q2 2021 after selling out during the quarter.
  • DAFNA Capital Management sold 430,111 Applied Genetic Technologies Corporation shares in Q2 2021, an estimated $2.18M.
  • DAFNA Capital Management first reported a position in Applied Genetic Technologies Corporation in Q1 2015 and held it in 25 quarters.
  • DAFNA Capital Management's Applied Genetic Technologies Corporation position peaked at $6.43M in Q2 2020.
  • 71 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2021.

Based on DAFNA Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.